Back to filter
Original filing (PDF)20250611105950NAL0013905891001
NAVROGEN, INC.
Form 5500-SF
FILING_RECEIVED
NAVROGEN, INC. 401(K) P/S PLAN
401(k) retirement plan
Active participants
4
Accounts w/ balance
4
Plan assets (EOY)
$3.0M
Net assets (EOY)
$3.0M
Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
100
Helping the score
- Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
- No Schedule C compensation disclosed — likely a small plan or unbundled.
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for NAVROGEN, INC..
Plan sponsor
Name
NAVROGEN, INC.
EIN
83-0595762
Address
66 MOUNT AIRE FARM RD · GLEN MILLS, PA · 19342
Phone
(610) 399-2717
Industry
Manufacturingsee all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-06-11
Pension benefit codes
2S · Automatic enrollment
2E · Profit-sharing
3D · Pre-approved plan (master / prototype / VS)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2F · ERISA section 404(c)
2T · Default investment account (QDIA)
Audit & trust (Schedule H)
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
Service providers (Schedule C)
Small plans don't disclose service providersRelated plans
Similar-size Manufacturing plans
TELIOS PHARMA, INC.
TELIOS PHARMA, INC. 401(K) PLAN
$3.0M · 25 participants
AGILE THERAPEUTICS, INC.
AGILE THERAPEUTICS, INC. 401(K) PROFIT SHARING PLAN
$3.1M · 19 participants
LEE BIOSOLUTIONS, INC.
LEE BIOSOLUTIONS, INC. 401(K) PLAN
$3.1M · 70 participants
POWDERSIZE LLC DBA MICROSIZE
POWDERSIZE 401K PLAN
$3.0M · 20 participants
DIABETIC AND PRESCRIPTION CENTER
DIABETIC AND PRESCRIPTION CENTER SAFE HARBOR 401(K) PLAN
$3.0M · 37 participants
ENGRAIL THERAPEUTICS, INC.
ENGRAIL THERAPEUTICS, INC. 401(K) PROFIT SHARING PLAN
$3.1M · 22 participants
Large plans in Pennsylvania
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II
$223.1B
VANGUARD FIDUCIARY TRUST COMPANY
VFTC INSTITUTIONAL 500 INDEX TRUST
$183.5B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2035 MASTER TRUST
$116.3B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2045 MASTER TRUST
$109.4B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2040 MASTER TRUST
$108.2B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2030 MASTER TRUST
$106.2B